Unique ID issued by UMIN | UMIN000028244 |
---|---|
Receipt number | R000032239 |
Scientific Title | Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study |
Date of disclosure of the study information | 2017/07/18 |
Last modified on | 2017/07/14 17:01:17 |
Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study
Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study
Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study
Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study
Japan |
Globus pharyngeus
obstructive sleep apnea (OSA)
gastroesophageal reflux disease (GERD)
Gastroenterology | Oto-rhino-laryngology |
Others
NO
We investigate the epidemiological frequency of the presence or absence of OSA and the presence or absence of GERD in patients with globus pharyngeus.
Others
When the patient with globus pharyngeus had OSA , we verify that symptoms of globus pharyngeus improve by CPAP treatment.
Exploratory
Simultaneously PSG and 24-hour pH monitoring
are performed on patients with globus pharyngeus, and the prevalence rate of OSA andGERD is obtained.
Patients with OSA are treated with CPAP.
Compare the VAS of symptoms of globus pharyngeus before treatment and 3 months after treatment and evaluate improvement.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patients who have non-painful sensation of a lump or foreign body in the throat for more than 3 months.
1)Patients who can not quit peptic ulcer treatment (PPI, H2 blocker,etc)
2)Patients with any mental disorder or
those who had been instructed to continue all medications that could influence sleep, such as benzodiazepines, were excluded as well.
3)other reasons inadequate for study
participation
30
1st name | |
Middle name | |
Last name | ayako fukui |
Nagoya city University
Department of otolaryngology
Mizuho-cho,Mizuho-ku,Nagoya,467-8601 JAPAN
052-851-5511
bunko-0406@hotmail.co.jp
1st name | |
Middle name | |
Last name | ayako fukui |
Nagoya city University
Department of otolaryngology
Mizuho-cho,Mizuho-ku,Nagoya,467-8601 JAPAN
052-851-5511
bunko-0406@hotmail.co.jp
Department of otolaryngology,Nagoya city University
Department of otolaryngology,Nagoya city University
Self funding
NO
名古屋市立大学大学病院
2017 | Year | 07 | Month | 18 | Day |
Unpublished
Open public recruiting
2013 | Year | 02 | Month | 01 | Day |
2013 | Year | 02 | Month | 01 | Day |
Exploratory epidemiology study
2017 | Year | 07 | Month | 14 | Day |
2017 | Year | 07 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032239
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |